Antibiotic usage for rotaviral diarrhea among children in Libya

Authors

  • Salem I. Alkoshi Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya
  • Kacey C. Ernst Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, The University of Arizona, Arizona state
  • Maznah B. Dahlui Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20151545

Keywords:

Medication, Antibiotics, Diarrhea, Rotavirus, Libya

Abstract

Background: In Libya, routine access to rotavirus testing is not available and clinicians treat presumptively, leading to inappropriate treatments. This study describes the management of rotavirus infection among Libyan children in public hospitals.

Methods:A prospective cross-sectional study was conducted to describe the management of rotavirus among children in three public hospitals in Libya from August 2012 to April 2013. We reviewed internal documents to determine if protocols were in place to guide management of diarrheal illness. Children under five presenting with diarrhea had stool samples collected and tested for rotavirus. Comparisons of treatments were made by rotavirus status and level of dehydration; mild, moderate and severe.

Results: A total of 545 diarrhea patients below 5 years of age were enrolled in the study. Of those, 311 (57%) cases were infected by rotavirus. Treatment was administered without investigating the cause of diarrhea. Intravenous fluids (IVF) treatment was the most common treatment for rotavirus cases and was administered to 306 (98%) of cases. Antibiotics were administered to about 137 (44%) of rotavirus cases. Antibiotics were more likely to be administered with more severe dehydration.

Conclusions:Presumptive treatment with antibiotics was very common in Libyan. Protocols for management of diarrheal illness and rotavirus cases in children need to be established for effective treatment.

References

Van Der A. Gastroenteritis in children. SA Pharmaceutical Journal. 2010;10.

WHO. Diarrhoeal Diseases. Initiative for Vaccine Research (IVR). Department of Immunization, Vaccines and Biologicals. 2009.

CDC. Rotavirus Surveillance. Worldwide, 2001—2008. Department of Health and Human Services. 2008;57(46):1255-7.

WHO. Rotavirus Bulletin. Western Pacific Region 1. 2009.

WHO. Rotavirus, 2009. Available at http://www.who.int/nuvi/rotavirus/en/. Accessed 15 March 2012.

Alkoshi S, Ernst K, Maimaiti N. Dahlui M. Rota Viral Infection: A Significant Disease Burden to Libya. Iranian Journal of Public Health. 2014;43:1356-63.

Van Der A. Gastroenteritis in children. SA Pharmaceutical Journal. 2010;10.

King C, Glass R, Bresee J, Duggan C. Managing acute gastroenteritis among children. MMWR Recomm Rep. 2003;52:1-16.

Elliott E, Acute gastroenteritis in children. BMJ: British Medical Journal. 2007;334:35.

Patient Educatiom Institute. Viral Gastroenteritis. Available at http://www.kaahe.org/en/ArabicSampleModules/modules/gastro/gefc01a1/gefc0101/gefc0101.pdf. 2013. Accessed 2 Jun 2014.

CDC. Rotavirus. 2013. Available at http://www.cdc.gov/rotavirus/index.html Accessed 15 March 2011.

WHO. Clinical Management of Acute Diarrhoea. Department of Child and Adolescent Health and Development Family and Community Health. 2004.

Shek K, Ng P, Hung C, Lam K, Lau C, Ching W. A review on the management of acute gastroenteritis in children. Hong Kong Journal of Emergency Medicine. 2004.

Kotwani A, Chaudhury R, Holloway K. Antibiotic-Prescribing Practices of Primary Care Prescribers for Acute Diarrhea in New Delhi, India. Value in health. 2012;15:S116-S119.

Alkoshi S, Leshem E, Parashar U, Dahlui M. Anticipating rotavirus vaccines–a pre-vaccine assessment of incidence and economic burden of rotavirus hospitalizations among children< 5 year of age in Libya, 2012-13. BMC Public Health. 2015;15:26.

Hanane K, Isla O, El Khoury Antoine D, Mireille G. Burden of rotavirus gastroenteritis in the Middle Eastern and North African pediatric population. BMC Infectious Diseases. 2009;11.

NCDC. Annual report for infectious disease in Libya. Surveillance department at NCDC. 2007.

IVAC. VIMS Report: Global Vaccine Introduction. 2013. Available at <http://www.jhsph.edu/research/centers-and-institutes/ivac/vims/IVAC-VIMS-Report-2013-Dec.pdf. Accessed 2 June 2014.

Alkoshi S, Smeo M, Dahlui M. A Review on Gastroenteritis Infection in Libya. Advanced Science, Engineering and Medicine. 2014;6:133-6.

WHO. Generic protocols for (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community-based survey on utilization of health care services for gastroenteritis in children: (Vaccines and Biologicals, World Health Organization. 2002.

Neale J. Research methods for health and social care. Palgrave macmillan. 2009;10:137-48.

Masters J. Gastroenteritis and the rotavirus vaccine, Health University of Bristol. 2007.

WHO. Diarrhoea Treatment Guidelines. 2005. Available at http://whqlibdoc.who.int/publications/2005/a85500.pdf?ua=1. Accessed 2 June 2014.

WGO. World Gastroenterology Organisation practice guideline: Acute diarrhea. 2008.

Chin J. Control of communicable diseases manual. American Public Health Association Washington, DC. 2000.

Vesteinsdottir I, Gudlaugsdottir S, Einarsdottir R, Kalaitzakis E, Sigurdardottir O, Bjornsson E. Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case–control study. European journal of clinical microbiology & infectious diseases. 2012;31:2601-10.

Horton D, Strom B, Putt M, Rose C, Sammons J. Clostridium difficile Infection‐Associated Reactive Arthritis in a Pediatric Cohort. Arthritis & Rheumatology. 2014;66:S82-S82.

Rodriguez S, Hernandez M, Tarchini G, Zaleski M, Vatanchi M, Cardona L. Risk of Clostridium difficile Infection in Hospitalized Patients Receiving Metronidazole for a Non-C difficile Infection. Clin Gastroenterol Hepatol. 2014;S1542-3565,00445-00445.

Kuriyama A, Jackson J, Doi A, Kamiya T. Metronidazole-induced central nervous system toxicity: a systematic review. Clinical neuropharmacology. 2011;34:241-7.

Burkhart D. Management of acute gastroenteritis in children. American Family Physician. 1999;60:2555.

Lazzerini M, Ronfani L. Oral zinc for treating diarrhoea in children. Cochrane Database; Syst Rev 3. 2008.

WHO. The treatment of diarrhoea. A manual for physicians and other senior health workers. Department of Child and Adolescent Health and Development. 1995.

Downloads

Published

2017-01-31

How to Cite

Alkoshi, S. I., Ernst, K. C., & Dahlui, M. B. (2017). Antibiotic usage for rotaviral diarrhea among children in Libya. International Journal Of Community Medicine And Public Health, 3(1), 37–41. https://doi.org/10.18203/2394-6040.ijcmph20151545

Issue

Section

Original Research Articles